Key facts

Spire Healthcare is a leading independent hospital group in the United Kingdom and the largest in terms of revenue. We deliver high standards of care, with integrity and compassion and from high-quality facilities to our insured, Self-pay and NHS patients.

From our 39 hospitals and eight clinics across England, Wales and Scotland, we provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. We are the principal independent provider by volume of knee and hip operations in the United Kingdom.

We also own and operate sports medicine, physiotherapy and rehabilitation brand, Perform. Working in partnership with over 7,300 experienced consultants, our hospitals delivered tailored, personalised care to 810,000 inpatients and day case patients in 2019.

The group was founded with the acquisition and rebranding of 25 Bupa hospitals in 2007. Since then, Spire Healthcare has made significant capital investments in its estate and continues to deliver successful and award winning clinical outcomes and high levels of patient satisfaction. Spire is listed on the London Stock Exchange.



Care delivered to almost 810,000 patients in 2019


of patients said they 'felt in safe hands'


of patients are 'Likely' or 'Extremely likely' to recommend Spire Healthcare



We work in partnership with almost 7,300 experienced Consultants


'satisfied' or 'very satisfied'



of colleagues feel fully engaged at work


of colleagues believe our top priority is delivering the highest quality patient care


of employees believe what they do at work makes a positive difference


We deliver value for money, price transparency, patient choice and additional capacity to help relieve pressure on overstretched NHS hospitals.

Our revenue comes from three sources: the NHS (29.9%), private medical insurance (51.4%) and Self-pay (18.7%)


The Board has proposed the payment of a total dividend of 3.8 pence per ordinary share for the year. This is consistent with 2019. We aim to continue to pay a dividend in line with our policy and to return excess cash to shareholders when available.